
FDA clears Pfizer’s Hympavzi for children with hemophilia B in expanded approval
Prime Highlights- The FDA approved Pfizer’s Hympavzi for children with hemophilia B aged 6 to

Prime Highlights- The FDA approved Pfizer’s Hympavzi for children with hemophilia B aged 6 to

Prime Highlights- ⦁ Roche and Nurix Therapeutics have signed a collaboration agreement worth up to

Prime Highlights Meiji Seika Pharma invested in the Global Health Security Fund. The fund supports

Prime Highlights Over 85% of previously untreated patients recorded a significant drop in cancer marker

Prime Highlights USM Healthcare is Vietnam’s only domestic stent manufacturer with a fully integrated production

Prime Highlights- Park Medi World approved the acquisition of V3 Healthcare Private Limited in a

Prime Highlights Roche and Medicines Patent Pool signed a licensing agreement to expand access to

Prime Highlights- Jersey’s Mental Health Recovery Hub launched a new website with an easier online

Prime Highlights China scored 85.3 points, ranking third behind the US and UK in Deep

Prime Highlights- Daiichi Sankyo aims to generate over 2.3 trillion yen in oncology revenue by